Status:
COMPLETED
Safety Analysis of Chronic Intake of a β-alanine Supplement
Lead Sponsor:
Universidad Católica San Antonio de Murcia
Conditions:
Product Safety
Eligibility:
MALE
18-40 years
Phase:
NA
Brief Summary
Single-center, double-blind, placebo-controlled clinical trial with two arms (product and placebo) to analyze the safety of beta-alanine consumption in active people.
Detailed Description
After recruitment, subjects will be randomized and assigned to one of the two arms of the study: beta-alanine group or control group (placebo). Subjects must be active people, and will take a dose of...
Eligibility Criteria
Inclusion
- Men between 18 and 40 years of age.
- Physically active people. They must train at least 3 sessions per week.
- Have been training continuously for at least one year.
Exclusion
- Participant suffering from chronic illness.
- Serious or terminal illness.
- Suffering from a lasting injury that prevents him/her from training in the month prior to the intervention.
- Inability to understand the informed consent.
- Previous experience in the consumption of beta alanine.
Key Trial Info
Start Date :
March 21 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2022
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05334121
Start Date
March 21 2022
End Date
May 31 2022
Last Update
July 26 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Catholic University of Murcia
Murcia, Spain, 30107